富乐德：10月23日召开董事会会议

Group 1 - The company Fulede (SZ 301297) announced that its 23rd meeting of the second board of directors will be held on October 23, 2025, in a communication format, where the profit distribution plan for the first three quarters of 2025 will be reviewed [1] - For the year 2024, Fulede's revenue composition is 100% from professional technical services [1] - As of the report, Fulede's market capitalization is 29.9 billion yuan [1] Group 2 - The Chinese innovative drug sector has sold overseas authorizations worth 80 billion USD this year [1] - There is a discussion on why the primary market is facing fundraising difficulties despite the hot secondary market in the biopharmaceutical industry [1]